1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in the United Kingdom

Biotechnology in the United Kingdom

  • November 2016
  • -
  • MarketLine
  • -
  • 34 pages

Summary
Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

Reasons To Buy
- What was the size of the United Kingdom biotechnology market by value in 2016?

- What will be the size of the United Kingdom biotechnology market in 2021?

- What factors are affecting the strength of competition in the United Kingdom biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United Kingdom's biotechnology market?

Key Findings
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The UK biotechnology market is expected to generate total revenues of $10.4bn in 2016, representing a compound annual growth rate (CAGR) of 5.7% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $6.9bn, equivalent to 66% of the market's overall value.

In 2015 the investment into UK biotechnology reached a 10 year high, helping narrow the funding gap to the United States having previously lost highly promising biotech start-ups to New York.

Table Of Contents

Biotechnology in the United Kingdom
Table of Contents
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
GE Healthcare
Novartis AG
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine


List of Tables
Table 1: United Kingdom biotechnology industry value: $ million, 2012-16(e)
Table 2: United Kingdom biotechnology industry category segmentation: $ million, 2016(e)
Table 3: United Kingdom biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: United Kingdom biotechnology industry value forecast: $ million, 2016-21
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: GE Healthcare: key facts
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Sanofi SA: key facts
Table 13: Sanofi SA: key financials ($)
Table 14: Sanofi SA: key financials (€)
Table 15: Sanofi SA: key financial ratios
Table 16: United Kingdom size of population (million), 2012-16
Table 17: United Kingdom gdp (constant 2005 prices, $ billion), 2012-16
Table 18: United Kingdom gdp (current prices, $ billion), 2012-16
Table 19: United Kingdom inflation, 2012-16
Table 20: United Kingdom consumer price index (absolute), 2012-16
Table 21: United Kingdom exchange rate, 2012-16


List of Figures
Figure 1: United Kingdom biotechnology industry value: $ million, 2012-16(e)
Figure 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2016(e)
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2016(e)
Figure 4: United Kingdom biotechnology industry value forecast: $ million, 2016-21
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2016
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2016
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2016
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2016
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2016
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2016
Figure 11: AstraZeneca PLC: revenues and profitability
Figure 12: AstraZeneca PLC: assets and liabilities
Figure 13: Novartis AG: revenues and profitability
Figure 14: Novartis AG: assets and liabilities
Figure 15: Sanofi SA: revenues and profitability
Figure 16: Sanofi SA: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

This report on the white biotechnology market studies the current as well as future prospects of the market globally. Environment concerns related to emission of greenhouse gases and dependence on non-renewable ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.